These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17975228)

  • 1. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established.
    Kang EM; Zickler PP; Burns S; Langemeijer SM; Brenner S; Phang OA; Patterson N; Harlan D; Tisdale JF
    Exp Hematol; 2005 Jun; 33(6):699-705. PubMed ID: 15911094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
    Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
    J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
    Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
    Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.
    Lee CH; Chen YG; Chen J; Reifsnyder PC; Serreze DV; Clare-Salzler M; Rodriguez M; Wasserfall C; Atkinson MA; Leiter EH
    Diabetes; 2006 Jan; 55(1):171-8. PubMed ID: 16380490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.
    Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Styche AJ; Trucco M
    Cell Transplant; 2002; 11(2):113-23. PubMed ID: 12099635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonobese diabetic natural killer cells: a barrier to allogeneic chimerism that can be reduced by rapamycin.
    Al-Adra DP; Chan WF; Anderson CC
    Transplantation; 2011 Nov; 92(9):977-84. PubMed ID: 21956197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance.
    Deng W; Han Q; Liao L; Li C; Ge W; Zhao Z; You S; Deng H; Zhao RC
    Exp Hematol; 2004 Sep; 32(9):861-7. PubMed ID: 15345288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.
    Plesner A; Worsaae A; Dyrberg T; Gotfredsen C; Michelsen BK; Petersen JS
    J Autoimmun; 1998 Aug; 11(4):335-41. PubMed ID: 9776711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.